-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
March 08, 2012 - Potential
comparative harms of intranasal corticosteroids in this population (reduced bone growth and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_executive.pdf
July 01, 2011 - Therefore, it is important to gather information on both
the benefits and harms of interventions in order
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-children_disposition-comments.pdf
December 19, 2016 - We also include a summary table in the ES and
main text that includes both benefits and harms
of strategies
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-212-urinary-incontinence-disposition-comments.pdf
August 08, 2018 - We have added to the limitations section a paragraph about
issues related to comparing benefits and harms
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/patient-participant-generated-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - PGRs and researchers need to be aware of potential ramifications
of privacy breaches, the potential harms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-response-cardio-dental.pdf
July 01, 2023 - research studies, four systematic reviews, and eight practice
guidelines that addressed the benefits and harms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-update_research-protocol.pdf
August 18, 2016 - .14
Adverse Effects of Diagnosis: Being diagnosed with ADHD could potentially lead to “labeling
harms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-centered-medical-home_disposition-comments.pdf
July 03, 2012 - Disposition of Comments Report for The Patient-Centered Medical Home
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1178
Published Online: July 3, 2012
Comparative Effectiveness Research Review Disposition of Comments Report
Researc…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-disposition.pdf
June 22, 2017 - concludes
by stating “While a large body of RCT
evidence exists on comparative
effectiveness and harms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_executive.pdf
February 01, 2014 - These areas include treatments
to achieve long-term remission, the benefits and harms
of step-up versus
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
January 01, 2025 - KQ 4 Outcomes (Harms)
First Author Last Name Year of Publication KQ 4 Harm Outcomes
Buchanan 2024 Authors … KQ 5 Outcomes (Harms)
First Author Last Name Year of Publication KQ 5 Harm Outcomes
Lennon 2020 Of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
January 01, 2025 - KQ 4 outcomes (harms)
First Author Last Name Year of Publication KQ 4 Harm Outcomes
Buchanan 2024 Authors … KQ 5 outcomes (harms)
First Author Last Name Year of Publication KQ 5 Harm Outcomes
Lennon 2020 Of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-insulin_executive.pdf
September 01, 2008 - Layout 1
Background and Key
Questions
Although oral antidiabetic agents are used
as first-line agents in patients with type 2
diabetes, insulin is required in a significant
number of patients at some stage during
the management of diabetes to maintain
optimal glycemic control. Insulin use has
been suggested as a fir…
-
effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
October 01, 2007 - ORIGINAL ARTICLE
Evaluation and Overview of the National Electronic Injury
Surveillance System-Cooperative Adverse Drug Event
Surveillance Project (NEISS-CADES)
Michael A. Jhung, MD, MPH,* Daniel S. Budnitz, MD, MPH,* Aaron B. Mendelsohn, PhD,*†
Kelly N. Weidenbach, MPH,* Theresa D. Nelson, MS,‡ and Daniel A. Polloc…
-
effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
October 01, 2007 - ORIGINAL ARTICLE
Real-Time Vaccine Safety Surveillance for the Early
Detection of Adverse Events
Tracy A. Lieu, MD, MPH,*† Martin Kulldorff, PhD,* Robert L. Davis, MD, MPH,‡
Edwin M. Lewis, MPH,§ Eric Weintraub, MPH,‡ Katherine Yih, PhD, MPH,* Ruihua Yin, MS,*
Jeffrey S. Brown, PhD,* and Richard Platt, MD, MSc,* for…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-indicators-symposium_research.pdf
April 01, 2010 - Table 1
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of
AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that
support the rapid development of new scientific information and analytic tools. The DEcIDE
network assists health ca…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive.pdf
October 01, 2015 - 1
Comparative Effectiveness Review
Number 156
Contrast-Induced Nephropathy: Comparative
Effectiveness of Preventive Measures
Executive Summary
Background
The administration of iodinated contrast
media is an essential component of many
diagnostic and therapeutic procedures
that involve radiologic imaging. One
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - CER # 23:
Effectiveness of Recombinant Human Growth Hormone (rhGH)
in the Treatment of Patients with Cystic Fibrosis
Original release date:
October 2010
Surveillance Report 1st Assessment: November, 2011
Surveillance Report 2nd Assessment: August 2012
Key Findings 1st Assessment:
• All conclusions for KQ…
-
effectivehealthcare.ahrq.gov/health-topics/child-safety
-
effectivehealthcare.ahrq.gov/health-topics/pregnancy-and-medicines